iPac-02 trial
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2740711
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: mFOLFOX6 + bevacizumab + IP PTX therapy:1 course for 14 days
intraperitoneal paclitaxel on days 1 and 8, Intravenous infusion of bevasizumab (Bmab), levofolinate (l-LV), oxaliplatin (L-OHP), followed by bolus of fluorouracil (5-FU) on day 1.
CAPOX + bevacizumab + IP PTX therapy:1 course for 21days
intraperitoneal paclitaxel on days 1, 8 and 15, Intravenous infusion of bevasizumab (Bmab) and oxaliplatin (L-OHP) on day 1, oral Capecitabine on days 1-14.
Primary outcome(s): Response rate
Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose
创建时间：
2023-05-15
